A nicotinic acetylcholine receptor mutation conferring target-site resistance to imidacloprid in Nilaparvata lugens (brown planthopper) by Liu, Z. et al.
A nicotinic acetylcholine receptor mutation
conferring target-site resistance to imidacloprid
in Nilaparvata lugens (brown planthopper)
Zewen Liu*, Martin S. Williamson†, Stuart J. Lansdell‡, Ian Denholm†, Zhaojun Han*§, and Neil S. Millar‡
*Key Laboratory of Monitoring and Management of Plant Diseases and Insects, Ministry of Agriculture, Nanjing Agricultural University, Nanjing 210095,
China; †Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, United Kingdom; and ‡Department of Pharmacology, University College London,
Gower Street, London WC1E 6BT, United Kingdom
Communicated by John E. Casida, University of California, Berkeley, CA, April 18, 2005 (received for review September 24, 2004)
Neonicotinoids, such as imidacloprid, are nicotinic acetylcholine
receptor (nAChR) agonists with potent insecticidal activity. Since its
introduction in the early 1990s, imidacloprid has become one of the
most extensively used insecticides for both crop protection and
animal health applications. As with other classes of insecticides,
resistance to neonicotinoids is a significant threat and has been
identified in several pest species, including the brown planthopper,
Nilaparvata lugens, a major rice pest in many parts of Asia. In this
study, radioligand binding experiments have been conducted with
whole-body membranes prepared from imidacloprid-susceptible
and imidacloprid-resistant strains of N. lugens. The results reveal a
much higher level of [3H]imidacloprid-specific binding to the sus-
ceptible strain than to the resistant strain (16.7  1.0 and 0.34 
0.21 fmolmg of protein, respectively). With the aim of under-
standing the molecular basis of imidacloprid resistance, five nAChR
subunits (Nl1–Nl4 and Nl1) have been cloned from N. lugens. A
comparison of nAChR subunit genes from imidacloprid-sensitive
and imidacloprid-resistant populations has identified a single point
mutation at a conserved position (Y151S) in two nAChR subunits,
Nl1 and Nl3. A strong correlation between the frequency of the
Y151S point mutation and the level of resistance to imidacloprid
has been demonstrated by allele-specific PCR. By expression of
hybrid nAChRs containing N. lugens  and rat 2 subunits, evi-
dence was obtained that demonstrates that mutation Y151S is
responsible for a substantial reduction in specific [3H]imidacloprid
binding. This study provides direct evidence for the occurrence of
target-site resistance to a neonicotinoid insecticide.
crop protection  insecticide resistance  nicotinic receptor
Imidacloprid is a nicotinic acetylcholine receptor (nAChR)agonist with potent insecticidal activity. It was the first member
of the neonicotinoid class of insecticides to be commercialized
(in 1991) and is used extensively for both crop protection and
animal health applications. Indeed, neonicotinoid insecticides
are now estimated to have annual worldwide sales of $1 billion
(1). Although nAChRs are important excitatory, neurotransmit-
ter-gated ion channels in both vertebrates and invertebrates, the
selective toxicity of neonicotinoids for insects has been attrib-
uted, at least in part, to their high affinity for insect receptors
(1–3). Nicotinic receptors are pentameric transmembrane com-
plexes assembled from a diverse family of subunit subtypes (4, 5).
In the model insect species Drosophila melanogaster, 10 nAChR
subunits have been identified by molecular cloning (5). An
important question, which is now being examined by studies of
both native and recombinant nAChRs (5–7), is the contribution
of particular nAChR subunits to the pharmacological and
physiological properties of this diverse family of receptors.
Insecticide resistance is a major worldwide problem for the
effective control of insect pests. Resistance has emerged in field
populations of insects to all major insecticide classes, including
organophosphates, carbamates, pyrethroids, and neonicotinoids
(8–10). Since the introduction of imidacloprid, evidence of
resistance has been slow to emerge but now involves a number
of important insect pests (10). In the best-studied example of
neonicotinoid resistance, involving the whitefly Bemisia tabaci,
resistance is attributable to enhanced oxidative detoxification of
neonicotinoids by overexpressed monooxygenases, rather than
to target-site changes in nAChRs (11). For other major insec-
ticide classes, both target-site modifications and enhanced de-
toxification have been identified as being important resistance
mechanisms (12). Examples of target-site changes include a
highly conserved mutation in the insect GABAA receptor sub-
unit (rdl) that confers resistance to dieldrin and other cyclo-
dienes in a range of insects (13, 14), mutations in the insect Na
channel that confer resistance to pyrethroid and diphenylethane
(e.g., DDT) insecticides (9, 15, 16), and mutations in acetylcho-
linesterase, the target site of organophosphate and carbamate
insecticides (17, 18). To date, however, there is no direct
evidence of target-site resistance to neonicotinoids occurring in
nAChR subunits.
Recently, evidence has been obtained for resistance to imi-
dacloprid in the brown planthopper Nilaparvata lugens, a major
rice pest (19). The lack of cross-resistance to other insecticide
classes and the lack of marked synergism by inhibitors of
detoxifying enzymes suggested that resistance might be due to a
mutation within the target site of imidacloprid rather than due
to enhanced detoxification (19). To examine this possibility, five
nAChR subunits (Nl1–Nl4 and Nl1) were cloned from N.
lugens. By comparison of nAChR subunit sequences from imi-
dacloprid-susceptible and resistant N. lugens strains, a mutation
was identified in two nAChR  subunits at a position close to the
predicted agonist binding site. To examine the influence of the
mutation on nicotinic agonist binding, cloned N. lugens nAChR
subunit cDNAs were expressed in a cultured Drosophila cell line
(as hybrid receptors with the rat nAChR 2 subunit). These
studies have provided clear evidence for the resistance-
associated mutation playing a direct role in neonicotinoid in-
secticide binding.
Materials and Methods
Brown Planthopper (N. lugens). The susceptible (S) strain of N.
lugens was a laboratory strain, obtained from Jiangsu Academy
of Agricultural Sciences (Nanjing, China) in April 2000, which
had been collected before imidacloprid application and reared in
a greenhouse for 10 years. The imidacloprid-resistant (R)
strains were laboratory strains selected from a field population
originally collected from hybrid paddy rice in Jiangpu, Jiangsu,
China, in August 2000. Selection of imidacloprid-resistant N.
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lugens with a resistance ratio of 73-fold after 25 generations
(T25) was described in ref. 19. After further selection, the
resistance ratio after 35 generations (T35) had increased to
250-fold (20). All test insects were reared in the laboratory at
25  1°C and 16-h light8-h dark photoperiod.
Extraction of the Membrane Protein from Planthoppers. Membranes
were prepared from N. lugens by using methods described in ref.
21. N. lugens (3-day-old female; 2 mg) were homogenized in 2 ml
of extraction buffer [pH 7.2, 0.32 mM sucrose100 M
EDTA1% proteinase inhibitor mixture I (Sigma)]. The homog-
enate was centrifuged at 1,000  g for 30 min. The resultant
supernatant was filtered through four layers of cheesecloth and
centrifuged at 30,000  g for 60 min. The pellet was resuspended
in the incubation buffer (pH 7.4, 0.05 mM Tris0.12 mM
NaCl100 M EDTA). Protein content was determined by a
Bio-Rad DC protein assay using BSA as standard.
Oligonucleotide Primers. Degenerate primers, BP1 (ATTCA
ATG ACN ACN AATC GTN TGG), BP2 (ATG AAGA
TTCT GGN TCN TGG AC), and BP3 (ACI GTGA TAGA
AAN AGAN GTCT TT), were designed from the conserved
N-terminal regions of insect nAChR subunits (22). Gene-
specific primers were based on the nucleotide sequences of
individual genes.
RT-PCR and Rapid Amplification of cDNA Ends (RACE). Total RNA was
isolated from adult females by TRIzol kit (Invitrogen). Synthesis
of first-strand cDNAs and RT-PCR were performed as described
in ref. 16. RACE was carried out by using the Smart Race cDNA
Amplification kit (Clontech) according to the manufacturer’s
instructions.
Cloning and Sequencing. PCR fragments were recovered from
agarose gels by using the Wizard PCR Preps DNA gel extraction
kit (Promega) and then cloned into the pGEM-T vector (Pro-
mega), and plasmid DNAs were prepared by using the Plasmid
Purification kit (Promega). Plasmid DNAs (200–500 ng) and
PCR fragments (30–90 ng) were used as templates for Taq Dye
terminator cycle sequencing reactions (PE Biosystems, Foster
City, CA). To verify the genotypes of individual susceptible and
resistant planthoppers, genomic DNA was extracted from single
insects and short (200-bp) fragments were amplified by PCR.
Amplified fragments were cloned, and three to four independent
cDNA clones were sequenced from each individual.
Allele-Specific PCR. The genotype of susceptible and resistant
planthoppers was examined by using the bidirectional amplifi-
cation of specific alleles method (23). Primers were designed to
permit detection of the Y151S mutation in the gene encoding the
Nl1 subunit. PCR amplification was performed on genomic
DNA from single insects with the following oligonucleotide
primers: P (ACA CGT CCC CAG TGA GCA), Q (GTC GGT
GGA ATG ATC TGT GC), A (ggg ggg ggc cGT TTG GAT CCT
GTA CAT C), and B (ggg ggg ggc gCA TGA TTG CCG TCG
T), by using methods described in ref. 23. PCR was performed
for 35 cycles of 30 sec at 94°C, 30 sec at 58°C, and 60 sec at 72°C.
Amplified bands were detected by agarose gel electrophoresis
and comprised (i) a 900-bp ‘‘common’’ fragment from all
individuals (primers P and Q), (ii) a 540-bp fragment amplified
from individuals with the wild-type (Y151) allele (primers P and
B), and (iii) a 370-bp fragment from individuals with the mutant
(S151) allele (primers Q and A). The presenceabsence of the
540- and 370-bp fragments allowed all insects to be genotyped
rapidly as wild-type homozygote (540 bp), mutant homozygote
(370 bp), or heterozygote (540 bp plus 370 bp) for this allele.
Epitope Tagging. To facilitate protein detection by Western
blotting, a recombinant epitope tag was introduced into Nl1
and Nl1Y151S cDNAs. In both cases, the nine amino acid
influenza hemagglutinin (HA) epitope (YPYDVPDYA) was
introduced within the predicted large (M3–M4) intracellular
loop region to create plasmids pRmHa3-Nl1HA and pRmHa3-
Nl1Y151S-HA. Mutagenesis was performed by using the
QuikChange method (Stratagene), and all mutated cDNAs were
verified by nucleotide sequencing.
Heterologous Expression in Drosophila S2 Cells. N. lugens nAChR
subunit cDNAs were subcloned into plasmid expression vector
pRmHa3, which contains an inducible metallothionein promoter
(24). Because the Nl1 and Nl4 subunit cDNAs were incom-
plete at their 5 ends, chimeras of these subunits were con-
structed in pRmHa3 in which the signal peptide and 16 amino
acids at the N terminus of the predicted mature protein were
replaced by the corresponding region of the Drosophila D2
SAD subunit. Schneider’s Drosophila S2 cells were maintained
and transfected by a modified calcium phosphate method, as
described in refs. 25 and 26. Cells were transfected with plasmid
pRmHa3 containing appropriate nAChR subunit cDNAs. Ex-
pression of nAChR subunit cDNAs from the metallothionein
promoter of pRmHa3 was induced by the addition of CuSO4 (0.6
mM) for 24 h.
Radioligand Binding. [3H]Epibatidine [48 Ci (1 Ci  37 GBq)
mmol)] was purchased from NEN. [3H]Imidacloprid (32 Ci
mmol) was generously provided by Bayer HealthCare, Mon-
heim, Germany. Radioligand binding to membrane preparations
and transiently transfected S2 cells was described in ref. 27.
Samples were assayed by filtration onto Whatman GFB filters
presoaked in 0.5% polyethylenimine, followed by rapid washing
by using a cell harvester (Brandel, Bethesda, MD). Amounts of
total protein were determined by a Bio-Rad DC protein assay
using BSA standards.
Immunoblotting. To confirm the expression of Nl1 and
Nl1Y151S nAChR subunits, HA-tagged subunit cDNAs
(Nl1HA and Nl1Y151S-HA) were expressed by transient trans-
fection in Drosophila S2 cells. Immunoblotting was performed as
described in refs. 28 and 29. Total cellular protein (200 g) from
transfected S2 cells was separated by SDSPAGE and then
electroblotted onto Hybond-C nitrocellulose membranes (Am-
ersham Pharmacia). Membranes were blocked and then incu-
bated with 1:1,200 dilution of mAbHA-7 (Sigma) for 1 h at room
temperature. The nitrocellulose membrane was washed thor-
oughly, incubated with 1:1,200 dilution of horseradish peroxi-
dase-conjugated goat anti-mouse IgG (Pierce), and processed by
using the enhanced chemiluminescence detection system (Am-
ersham Pharmacia).
Results
Radioligand Binding to nAChRs from Imidacloprid-Susceptible and
Imidacloprid-Resistant N. lugens. High-affinity specific binding of
[3H]imidacloprid was detected in whole-body membrane prep-
arations from an imidacloprid-susceptible strain of the brown
planthopper N. lugens (Fig. 1A), as was reported for other insect
species in refs. 21 and 30–33. Initial saturation radioligand-
binding studies revealed two high-affinity binding sites for
imidacloprid (Kd  0.01 nM and 1.5 nM; Fig. 1) to native
nAChRs from N. lugens. These findings are in close agreement
with previous reports that imidacloprid binds with high affinity
to two sites (Kd  0.004 nM and 1.2 nM) in membrane
preparations from the leafhopper Nephotettix cincticeps (21).
Further binding studies were performed with membranes iso-
lated from imidacloprid-susceptible (S) and imidacloprid-
resistant (R-T35) strains of N. lugens (20). Much higher levels of



































specific [3H]imidacloprid binding were detected in membranes
isolated from the imidacloprid-susceptible strain (16.7  1.0
fmolmg of protein; n  3; Fig. 1 A) than in membranes isolated
from the resistant strain (0.34  0.21 fmolmg of protein, n 
3; Fig. 1 A). The low level of specific binding observed with the
resistant strain precluded an accurate estimate of binding affin-
ity. These observations provide strong evidence to suggest that
resistance to imidacloprid in N. lugens is a consequence of a
modification to the target site. To examine the ability of sus-
ceptible and resistant insects to bind other nicotinic agonists,
radioligand binding was performed with [3H]epibatidine. As had
been observed with [3H]imidacloprid, higher levels of specific
epibatidine binding were detected in the imidacloprid-
susceptible strain (14.3  1.2 fmolmg of protein; n  3; Fig. 1B)
than in resistant insects (2.6  0.6 fmolmg of protein; n  3;
Fig. 1B).
Molecular Cloning of nAChR Subunits from N. lugens. Five different
partial cDNA fragments were cloned from N. lugens by RT-PCR
using degenerate primers designed to previously cloned insect
nAChR subunit genes. These fragments were extended 5 and 3
by using RACE techniques to yield three full-length cDNAs and
two almost-full-length cDNAs that lacked signal peptides and a
short sequence of the N-terminal coding region. An alignment
of the deduced protein sequences of these genes is shown in
Fig. 2.
The cloned genes contained a single long ORF, the amino acid
sequence of which showed clear sequence similarity to previously
cloned nAChR subunits (Fig. 2) and features characteristic of
the nAChR gene family (34). All sequences contained four
hydrophobic putative transmembrane domains and a pair of
cysteine residues [at positions 128 and 142; numbered according
to the Torpedo 1 subunit (35)], believed to form a 15-aa
disulfide-linked loop characteristic of ligand-gated ion channels.
Based on their relative sequence similarity to nAChR subunits
from Drosophila, the putative planthopper nAChR subunits
were named as Nl1 (73% similarity to D1ALS), Nl2 (63%
similarity to D2SAD), Nl3 (56% similarity to D3), Nl4
(32% similarity to D4), and Nl1 (63% similarity to D1
ARD). Nl4 has low sequence similarity to all known Drosophila
subunits and may not, therefore, be the true orthologue of D4.
An unusual feature of the Nl1 subunit is the presence of
charged residues within its predicted fourth transmembrane
(M4) domain (Fig. 2). It is possible that this unusual M4 domain
is a consequence of alternative splicing; however, two indepen-
dently isolated cDNA clones, which differed in the presence and
absence of an N-terminal exon (accession nos. AY378703 and
AY378704), had identical sequences in their M4 domain.
Identification of Potential Resistance-Related Mutations. Compari-
son of cDNA sequences of the four  subunits cloned from
susceptible (S) and resistant (R) strains revealed several amino
acid polymorphisms. However, only one of these polymorphisms
(in both Nl1 and Nl3) was found to be associated with
imidacloprid resistance. This polymorphism corresponds to the
replacement of a tyrosine (Y) residue with a serine (S) residue
at a position equivalent to Y151 in mature Torpedo nAChR 1
subunit (see Fig. 2). Although the amino acid numbering of Nl1
and Nl3 differs slightly from that of the Torpedo 1 subunit, this
residue is referred here to Y151, to assist in comparisons with
studies of other nAChR subunits. To examine the correlation
between these mutations and resistance, the genomic sequence
encoding this region of the Nl1 and Nl3 subunits was ampli-
fied by PCR. Twenty-two imidacloprid-susceptible (S) and 27
imidacloprid-resistant (R-T35) planthoppers were examined
(see Materials and Methods). All susceptible individuals had
tyrosine at this site in both Nl1 and Nl3, whereas all resistant
individuals contained a serine at this position in both Nl1 and
Nl3. The bidirectional amplification of specific alleles method
(23) was used to further characterize the genotype of susceptible
and resistant planthoppers at position Y151 in the gene encoding
Nl1 (Table 1). At generation 25, when resistance to imidaclo-
prid was 73-fold (19), 59 of 70 individuals tested (84%) were
heterozygous for Y151S, and the remaining 11 (16%) were
homozygous for the mutation. By generation 35, when resistance
had reached 250-fold (20), all insects tested were homozygous
for the mutation.
Recombinant nAChRs Expressed in Drosophila S2 Cells. To facilitate
heterologous expression in Drosophila S2 cells, N. lugens nAChR
subunit cDNAs were subcloned into the Drosophila expression
vector pRmHa3. As previously described in refs. 22 and 26,
initial characterization of recombinant nAChRs containing in-
sect and vertebrate (rat) nAChR subunits was conducted with
[3H]epibatidine. As has been found with nAChR subunits cloned
from other insect species (22, 26, 36), no specific radioligand
binding could be detected with any combination of N. lugens
nAChR subunits. Despite difficulties in heterologous expression
of insect nAChR subunits, a strategy that has proved successful
with several insect species is to coexpress insect nAChR 
subunits with a vertebrate non- subunit such as rat 2 (26, 27,
37). Each of the four N. lugens  subunits (Nl1–Nl4) was
coexpressed with the rat 2 subunit by transient transfection in
Drosophila S2 cells. No specific binding of [3H]epibatidine or of
other nicotinic radioligands (such as [3H]methyllycaconitine)
could be detected in cells transfected with Nl3 plus 2 or Nl4
plus 2, but specific binding of [3H]epibatidine was detected in
cells transfected with Nl1 plus 2 and Nl2 plus 2.
To examine the influence of the Y151S mutation upon
nicotinic radioligand binding, Drosophila S2 cells were cotrans-
fected with Nl1 plus 2 or Nl1Y151S plus 2 subunit combi-
nations. Equilibrium saturation binding experiments were per-
formed to determine Bmax and Kd values for binding of
[3H]epibatidine. Specific binding of [3H]epibatidine was de-
tected in cells transfected with Nl1 plus 2 (Bmax  64.5  0.8
fmolmg of protein; n  3; Fig. 3) and was of high affinity (Kd 
0.32  0.04 nM, n  3). Specific binding of [3H]epibatidine also
was detected in cells transfected with Nl1Y151S plus 2, but at
significantly lower levels (Bmax  2.0  0.04 fmolmg of protein,
Fig. 1. Radioligand binding to native N. lugens nAChRs. (A) Equilibrium
saturation binding was performed with [3H]imidacloprid on whole-body
membranes prepared from imidacloprid-susceptible N. lugens. Data points
are means of triplicate samples. (Inset) Summary of binding data obtained
with susceptible (S) and resistant (R) N. lugens. Specific binding of [3H]imida-
cloprid was detected in membranes isolated from the susceptible strain. In
contrast, only very low levels of [3H]imidacloprid binding could be detected to
the membranes from the resistant strain. (B) Binding of [3H]epibatidine to
imidacloprid-susceptible and imidacloprid-resistant N. lugens. Specific bind-
ing of [3H]epibatidine was detected in the susceptible strain, but significantly
lower levels were detected in resistant insects.






















n  3; Fig. 3). This decrease corresponds to about a 32-fold lower
level of specific binding than was detected with Nl1 plus 2.
Due to the low levels of specific binding detected with the
Nl1Y151S plus 2 subunit combination, it was difficult to
determine the affinity of binding accurately, which nonetheless
did not appear to be significantly different from that observed
with Nl1 plus 2.
Competition binding experiments were carried out to examine
the influence of the Y151S mutation upon imidacloprid binding
(Fig. 3). In cells transfected with Nl1 plus 2, imidacloprid
displaced [3H]epibatidine binding with high affinity (Ki  24.3 
2.3 nM, n  3; Fig. 3). Imidacloprid did not cause significant
displacement of the low level of [3H]epibatidine binding detected
in cells transfected with Nl1Y151S plus 2, even at concentra-
tions up to 10 M (data not shown). To examine more directly
the influence of the Y151S mutation upon imidacloprid binding,
the studies were performed with [3H]imidacloprid. In cells
transfected with Nl1 plus 2, specific binding of [3H]imidaclo-
prid was detected (Bmax  39.9  8.4 fmolmg of protein; n 
3; Fig. 4A). In contrast, no significant specific binding of
[3H]imidacloprid was detected in cells transfected with Nl1Y151S
plus 2 (Bmax  0.4  1.2 fmolmg of protein; n  3; Fig. 4A).
Detection of Nl1HA and Nl1Y151S-HA by Immunoblotting. Levels of
expressed Nl1 and Nl1Y151S subunit protein in transfected
Fig. 2. Amino acid sequence alignments of N. lugens nAChR subunits. Also shown are the sequences of the Drosophila D2SAD subunit and the Torpedo 1
subunit. Predicted signal peptide (SP) and transmembrane domains (M1–M4) are underlined. The location of six domains (loops A–F) believed to be important
in forming the agonistantagonist binding site also are indicated. Of these, three (loops A–C) are contributed by the  subunit interface and three (loops D–F)
by the non- interface in a heteromeric nAChR. The location of the mutation identified in this study (equivalent to Y151 of the Torpedo 1 subunit) is indicated
by an asterisk.
Table 1. Nl1Y151 genotype frequency in N. lugens
Population n
% homozygous
wild type % heterozygous
% homozygous
mutant
S 60 100 0 0
R (T25) 70 0 84 16
R (T35) 79 0 0 100
Nl1Y151 genotype frequency was examined by allele-specific PCR in three
populations of N. lugens: the imidacloprid-susceptible population (S) and two
resistant (R) populations. The resistant population isolated after 25 genera-
tions of selection with imidacloprid (T25) had a resistance ratio of 73 (19),
whereas the population isolated after 35 generations (T35) had a resistance
ratio of 250 (20).



































Drosophila S2 cells were examined by immunoblotting with
HA-tagged subunit cDNA constructs. The rationale was to
determine whether the low level of radioligand binding could be
attributed simply to low levels of expression of the Nl1Y151S
subunit. HA-tagged subunit cDNAs (Nl1HA and Nl1Y151S-HA)
were transfected into Drosophila S2 cells, and total cellular
proteins were separated by SDSPAGE. Samples were trans-
ferred to nitrocellulose filters and examined by immunoblotting
with a monoclonal antibody that recognizes the HA epitope
(mAbHA-7). A band of the expected molecular mass (66 kDa)
was detected in cells transfected with Nl1HA and Nl1Y151S-HA
but was absent from mock-transfected S2 cells (Fig. 4B). The
bands detected in cells transfected with Nl1H A and
Nl1Y151S-HA were of similar intensity, suggesting that the Y151S
mutation does not significantly alter levels of total subunit
protein.
Discussion
Imidacloprid, like other systemic insecticides, displays marked
residual persistence, which can generate prolonged selection
pressure for resistance (38). Resistance to imidacloprid has been
reported in a range of species including western flower thrips,
Colorado potato beetle, German cockroach, and house fly (39,
40). In silverleaf whitefly and green peach aphid, high resistance
was obtained by continuous selection in the greenhouse (41, 42).
Previous studies from this laboratory also have shown that the
brown planthopper (N. lugens) developed high resistance to
imidacloprid after continuous selection (19, 20). In some species
with high resistance to imidacloprid, piperonyl butoxide had very
strong synergistic effects on imidacloprid, suggesting that P450
monooxygenases may play important roles in imidacloprid re-
sistance (41, 42). Our previous studies of resistance to imida-
cloprid in N. lugens (19) revealed significant cross-resistance
only to the insecticides that target nAChRs, suggesting that
target insensitivity might play an important role in imidacloprid
resistance.
A point mutation (Y151S), associated with resistance to
imidacloprid in N. lugens, has been identified in two nAChR
subunits Nl1 and Nl3. These subunits exhibit high sequence
similarity to nAChR subunits from Drosophila (D1ALS and
D3), which have previously been shown to form a high-affinity
binding site for imidacloprid (27). Heterologous expression
studies with Nl1 or Nl1Y151S have revealed that the Y151S
mutation in Nl1 is responsible for a loss of specific imidacloprid
binding. Despite the absence of specific [3H]imidacloprid bind-
ing in transfected Drosophila S2 cells, immunoblotting data
confirm that the Y151S mutation has no significant effect on
levels of total Nl1 subunit protein expressed. Although the role
of such mutations in conferring target-site resistance to insec-
ticides is well documented, none of these reports relate to
neonicotinoids. The association between Y151S and imidaclo-
prid resistance shown by direct sequencing is supported further
by work using allele-specific PCR to measure the frequency of
Nl1 genotypes in insects collected at two time periods during
selection of the resistant strain. At generation 25, when resis-
tance to imidacloprid was 73-fold, 84% were heterozygous for
Y151S, and the remaining 16% were homozygous for the
mutation. By generation 35, when resistance had reached 250-
fold, all insects tested were homozygous for the mutation. This
finding is consistent with the concentrations of imidacloprid
used for selection, which were gradually increased as the exper-
iment progressed (19, 20).
An interesting feature of this work is the discovery of the same
mutation at homologous residues in two distinct nAChR 
subunits. This discovery raises the intriguing question of whether
both mutations are essential to generate a resistance phenotype,
or whether a single mutated subunit is sufficient to confer at least
some protection against imidacloprid. The configuration of
subunits in native receptors is unclear at present and requires
further investigation. Two possibilities are that either the sub-
units contribute to different populations of receptors, rendering
each of these resistant, or they occur together in a heteromeric
receptor. Interestingly, evidence for the existence of heteromeric
nAChRs containing two different -subunit subtypes has been
reported in Drosophila (43). The need for insects to contain two
mutated subunits to express resistance, if confirmed, has impor-
tant evolutionary implications in terms of the expected fre-
quency of resistant individuals in untreated populations and may
help to explain the apparent scarcity of target-site resistance to
these compounds, compared with enhanced detoxification (10).
Extensive photoaffinity labeling studies have been conducted
with nAChRs purified from the electric organ of the marine ray
Torpedo. This work, together with data derived from site-
directed mutagenesis and structural studies, has led to a model
in which the nAChR binding site lies at the interface of two
adjacent subunits. This model proposes that three amino acids
loops (loops A–C) are contributed by the ‘‘principal’’ subunit
and three (loops D–F) by the ‘‘complementary’’ subunit (44), see
Fig. 3. Characterization of hybrid (Nl1 plus rat 2 subunit) nAChRs ex-
pressed in Drosophila S2 cells. Specific binding of [3H]epibatidine was detected
in cells transfected with Nl1 plus 2 subunits but at significantly lower levels
in cells transfected with Nl1Y151S plus 2 (Inset). Competition binding with
imidacloprid in cells transfected with Nl1 and rat 2 subunits. Imidacloprid
displaced binding of [3H]epibatidine with high affinity (Ki  24.3  2.3 nM).
Data points are means of triplicate samples from a single experiment and are
typical of results obtain from three independent experiments.
Fig. 4. Characterization of Nl1 and Nl1Y151S subunits by radioligand
binding and immunoblotting. (A) A saturating concentration of [3H]imidaclo-
prid (100 nM) was used to examine binding to transfected Drosophila S2 cells.
In cells transfected with Nl1 plus 2, specific binding of [3H]imidacloprid was
detected. In contrast, no significant specific binding of [3H]imidacloprid was
detected in cells transfected with Nl1Y151S plus 2. (B) Total cellular proteins
(200 g) from Drosophila S2 cells transfected with Nl1Y151S-HA (lane 1), Nl1HA
(lane 2) or mock-transfected (lane 3) were separated by SDSPAGE. After
transfer to nitrocellulose, proteins were detected by immunoblotting with
mAbHA-7. Specific immunoreactive bands of apparent molecular mass 66
kDa were detected corresponding to Nl1Y151S-HA and Nl1HA (lanes 1 and 2).
Nonspecific bands of higher molecular mass are visible in all lanes.






















Fig. 2. Photoaffinity labeling studies of Torpedo nAChRs have
identified several aromatic residues believed to contribute to the
nAChR binding site, including Y151 within loop B (45). Com-
parison of nAChR subunit sequences with that of the acetyl-
choline binding protein (AChBP) from the mollusc Lymnaea
stagnalis (46) reveals significant sequence similarity. Residue
Y151 in nAChR  subunits is at a position analogous to a
histidine residue (H145) in the AChBP (46). X-ray diffraction
studies of the Lymnaea AChBP reveal that H145 forms part of
the AChBP agonist binding site (46). This finding, together with
the photoaffinity labeling studies conducted with Torpedo
nAChRs discussed above, supports the conclusion that Y151 is
located at or close to the agonist binding site in nAChR subunits.
The data presented provide evidence that Y151 plays an
important role in the binding of the neonicotinoid agonist
imidacloprid to insect nAChRs. However, because Y151 is highly
conserved between vertebrate and invertebrate nAChR sub-
units, this residue cannot be responsible for the excellent selec-
tivity of neonicotinoids such as imidacloprid for insect nAChRs
(1, 3). Whereas the binding of classical nicotinic agonists such as
nicotine is thought to require cation– interactions between the
ammonium nitrogen and aromatic residues within the nAChR
binding site (47), it has been proposed that the selectivity of
neonicotinoids for insect nAChRs is due to interactions between
an electronegative pharmacophore and a cationic subsite in the
receptor (48, 49). Given the likely close proximity of Y151 to the
nAChR agonist binding site (which, as discussed earlier, is
supported by the atomic resolution structure of the Lymnaea
AChBP), it seems plausible that the Y151S mutation might cause
an induced conformational change within the nAChR binding
site region that involves other amino acids, including those that
are essential for the selective binding of the electronegative
pharmacophore of neonicotinoid compounds.
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